Χώρα: Νέα Ζηλανδία
Γλώσσα: Αγγλικά
Πηγή: Medsafe (Medicines Safety Authority)
Betamethasone dipropionate 0.065%{relative} equivalent to 0.05% betmethasone; ; Betamethasone dipropionate 0.64 mg/g equivalent to 0.05% betmethasone
Organon (New Zealand) Limited
Betamethasone dipropionate 0.065% w/w (= 0.05% betmethasone)
0.05% w/w
Topical cream
Active: Betamethasone dipropionate 0.065%{relative} equivalent to 0.05% betmethasone Excipient: Cetomacrogol 1000 Cetostearyl alcohol Chlorocresol Liquid paraffin Monobasic sodium phosphate dihydrate Phosphoric acid Purified water White soft paraffin Active: Betamethasone dipropionate 0.64 mg/g equivalent to 0.05% betmethasone Excipient: Cetomacrogol 1000 Cetostearyl alcohol Chlorocresol Liquid paraffin Monobasic sodium phosphate dihydrate Phosphoric acid Purified water Sodium hydroxide White soft paraffin
Tube, 15g, 15 g
Prescription
Prescription
Crystal Pharma SA
Package - Contents - Shelf Life: Tube, - 15 g - 24 months from date of manufacture stored at or below 25°C - Tube, - 50 g - 24 months from date of manufacture stored at or below 25°C
1976-06-10
DIPROSONE ® 1 DIPROSONE ® _Betamethasone dipropionate _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Diprosone. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you using Diprosone against the benefits it is expected to have for you. IF YOU HAVE ANY CONCERNS ABOUT THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH YOUR MEDICINE. You may need to read it again. WHAT DIPROSONE IS USED FOR The name of your medicine is Diprosone. It contains the active ingredient called betamethasone dipropionate. It is a type of cortisone and belongs to the group of medicines called corticosteroids. Diprosone is classified as a high potency topical corticosteroid. There are three forms of Diprosone: cream, ointment and lotion. Diprosone is used on the skin to relieve the redness, swelling, itching and discomfort of many skin problems such as: • psoriasis (a stubborn skin disorder with raised, rough, reddened areas covered with dry, fine silvery scales) • eczema (an often itchy skin condition with redness, swelling, oozing of fluid, crusting which may lead to scaling) • other types of dermatitis Diprosone Lotion is also used on the scalp and hairy parts of the body. Your doctor may have prescribed Diprosone for another reason. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY DIPROSONE HAS BEEN PRESCRIBED FOR YOU. This medicine is available only with a doctor's prescription. BEFORE YOU USE DIPROSONE _WHEN YOU MUST NOT USE IT _ DO NOT USE DIPROSONE IF YOU HAVE HAD AN ALLERGIC REACTION, SUCH AS WHEEZING, RASH OR HIVES, TO DIPROSONE, ANY OTHER CORTICOSTEROID, OR ANY OF THE INGREDIENTS LISTED AT THE END OF THIS LEAFLET. DO NOT USE DIPROSONE IF YOU HAVE: • A VIRAL SKIN INFECTION, SUCH AS COLD SORES, SHINGLES OR CHICKEN POX • A FUNGAL SKIN INFECTION, SUCH AS THRUSH, TINEA OR RINGWORM • TUBERCULOSIS OF THE S Διαβάστε το πλήρες έγγραφο
1 S-CCDS-MK1460-DPS-MTL-082017 DATA SHEET 1. DIPROSONE ® DIPROSONE (0.05% w/w) cream DIPROSONE (0.05% w/w) ointment 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Betamethasone dipropionate equivalent to betamethasone 0.5mg/g (0.05% w/w). For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM DIPROSONE Cream is a white cream in a paraben-free water-washable vanishing cream base. DIPROSONE Ointment is an off-white ointment in a preservative-free ointment base. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS DIPROSONE is indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. These include atopic eczema, infantile eczema, nummular eczema, contact dermatitis, neurodermatitis, anogenital and senile pruritus, lichen planus, intertrigo and psoriasis. 4.2 DOSE AND METHOD OF ADMINISTRATION DIPROSONE Cream and Ointment: Apply a small amount to the affected area twice daily. For some patients adequate maintenance therapy may be achieved with once daily application. In most cases, 4 weeks continuous treatment should be considered the maximum. Children: Administration of topical corticosteroids to children should be limited to the least amount compatible with an effective therapeutic regimen. 4.3 CONTRAINDICATIONS Hypersensitivity to betamethasone dipropionate, other corticosteroids or any of the components. Like other topical corticosteroids, DIPROSONE preparations are contraindicated in viral infections of the skin, such as vaccinia, varicella and Herpes simplex, also tuberculosis, acne rosacea, fungal skin infections (moniliasis), perioral dermatitis and ulcerative conditions. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE DIPROSONE preparations should not be used in or near the eyes. If irritation or sensitisation develops, treatment should be discontinued and appropriate therapy instituted. In the presence of an infection, an appropriate antifungal or antibacterial agent should be administered. If a favourable response does not occur within a few da Διαβάστε το πλήρες έγγραφο